Multimodality Imaging for the Workup of Coronary Artery Disease

Tuesday, June 7 | 2:30 PM - 4:00 PM
Ballroom C2

Objectives
Upon completion of this activity, the participant will be able to:
1. Discuss the value of multimodality imaging in coronary artery disease.
2. Define the costs associated with potentially improved diagnostic accuracy with multimodality imaging.
3. Review clinically relevant information beyond perfusion that can be obtained by imaging.

Speakers are:
Mark I. Travin, MD, Montefiore Medical Center, Bronx, N.Y.;
Daniel S. Berman, MD, Cedars-Sinai Medical Center in Los Angeles;
Ahmed A. Tawakol, MD, Massachusetts General Hospital; and
Louise Thomson, MBChB, Cedars-Sinai Medical Center in Los Angeles.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.